Yuvanci (single tablet combination therapy [STCT] of macitentan and tadalafi) has been approved by the European Commission ...

Diversity and inclusion are critical to business success, particularly when fostering innovation and creativity. At Mednet, ...

Effective brand strategies are like a well-made jigsaw but they can end up looking nothing like the picture that was agreed ...

Public health, access to healthcare services, and food and nutrition are some of the most important issues facing people ...

Johnson & Johnson (J&J) and Legend Biotech have shared positive long-term results for their BCMA-directed T-cell ...

One of the candidates included in the deal has already shown promise in a phase 1a advanced breast cancer study ...

Women have played a crucial role in rare disease awareness and better care, overcoming gender biases and systemic challenges ...

Many initiatives have tried to address this partnership challenge: the Healthcare Communications Association’s (HCA) own ...

Bristol Myers Squibb (BMS) has announced positive results from a phase 3b/4 study of its oral TYK2 inhibitor Sotyktu ...

Ipsen’s Kayfanda (odevixibat) has been approved by the European Commission (EC) under exceptional circumstances to treat ...

More and more health data is being collected in the real-world about how that medicine works in a wider population than that ...

Medscape wants to take the opportunity to look back and recap what was accomplished at ESC 2024. At this year’s event, ...